Publications:
Geerts D, Koster J, Albert D, Koomoa DL, Feith DJ, Pegg AE, Volckmann R, Caron H, Versteeg R, Bachmann AS, (2009). The polyamine metabolism genes ornithine decarboxylase and antizyme 2 predict aggressive behavior in neuroblastomas with and without MYCN amplification.. Int J Cancer :.
Abstract

Revet I, Huizenga G, Koster J, Volckmann R, van Sluis P, Versteeg R, Geerts D, (2009). MSX1 induces the Wnt pathway antagonist genes DKK1, DKK2, DKK3, and SFRP1 in neuroblastoma cells, but does not block Wnt3 and Wnt5A signalling to DVL3.. Cancer Lett :.
Abstract

Molenaar JJ, Ebus ME, Geerts D, Koster J, Lamers F, Valentijn LJ, Westerhout EM, Versteeg R, Caron HN, (2009). Inactivation of CDK2 is synthetically lethal to MYCN over-expressing cancer cells.. Proc Natl Acad Sci U S A :.
Abstract

Stutterheim J, Gerritsen A, Zappeij-Kannegieter L, Yalcin B, Dee R, van Noesel MM, Berthold F, Versteeg R, Caron HN, van der Schoot CE, Tytgat GA, (2009). Detecting minimal residual disease in neuroblastoma: the superiority of a panel of real-time quantitative PCR markers.. Clin Chem 55:1316-26.
Abstract

Cimmino F, Schulte JH, Zollo M, Koster J, Versteeg R, Iolascon A, Eggert A, Schramm A, (2009). Galectin-1 is a major effector of TrkB-mediated neuroblastoma aggressiveness.. Oncogene 28:2015-23.
Abstract

Huang S, Laoukili J, Epping MT, Koster J, Holzel M, Westerman BA, Nijkamp W, Hata A, Asgharzadeh S, Seeger RC, Versteeg R, Beijersbergen RL, Bernards R, (2009). ZNF423 is critically required for retinoic acid-induced differentiation and is a marker of neuroblastoma outcome.. Cancer Cell 15:328-40.
Abstract

van Hooff SR, Koster J, Hulsen T, van Schaik BD, Roos M, van Batenburg MF, Versteeg R, van Kampen AH, (2009). The construction of genome-based transcriptional units.. OMICS 13:105-14.
Abstract

Missiaglia E, Selfe J, Hamdi M, Williamson D, Schaaf G, Fang C, Koster J, Summersgill B, Messahel B, Versteeg R, Pritchard-Jones K, Kool M, Shipley J, (2009). Genomic imbalances in rhabdomyosarcoma cell lines affect expression of genes frequently altered in primary tumors: an approach to identify candidate genes involved in tumor development.. Genes Chromosomes Cancer 48:455-67.
Abstract

Schulte JH, Lim S, Schramm A, Friedrichs N, Koster J, Versteeg R, Ora I, Pajtler K, Klein-Hitpass L, Kuhfittig-Kulle S, Metzger E, Schule R, Eggert A, Buettner R, Kirfel J, (2009). Lysine-specific demethylase 1 is strongly expressed in poorly differentiated neuroblastoma: implications for therapy.. Cancer Res 69:2065-71.
Abstract

Schulte JH, Pentek F, Hartmann W, Schramm A, Friedrichs N, Ora I, Koster J, Versteeg R, Kirfel J, Buettner R, Eggert A, (2009). The low-affinity neurotrophin receptor, p75, is upregulated in ganglioneuroblastoma/ganglioneuroma and reduces tumorigenicity of neuroblastoma cells in vivo.. Int J Cancer 124:2488-94.
Abstract

van Engelen K, Merks JH, Lam J, Kremer LC, Backes M, Baars MJ, van der Pal HJ, Postma AV, Versteeg R, Caron HN, Mulder BJ, (2008). Prevalence of congenital heart defects in neuroblastoma patients: a cohort study and systematic review of literature.. Eur J Pediatr :.
Abstract

Stutterheim J, Gerritsen A, Zappeij-Kannegieter L, Kleijn I, Dee R, Hooft L, van Noesel MM, Bierings M, Berthold F, Versteeg R, Caron HN, van der Schoot CE, Tytgat GA, (2008). PHOX2B is a novel and specific marker for minimal residual disease testing in neuroblastoma.. J Clin Oncol 26:5443-9.
Abstract

Kool M, Koster J, Bunt J, Hasselt NE, Lakeman A, van Sluis P, Troost D, Meeteren NS, Caron HN, Cloos J, Mrsic A, Ylstra B, Grajkowska W, Hartmann W, Pietsch T, Ellison D, Clifford SC, Versteeg R, (2008). Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features.. PLoS One 3:e3088.
Abstract

de Haas T, Hasselt N, Troost D, Caron H, Popovic M, Zadravec-Zaletel L, Grajkowska W, Perek M, Osterheld MC, Ellison D, Baas F, Versteeg R, Kool M, (2008). Molecular risk stratification of medulloblastoma patients based on immunohistochemical analysis of MYC, LDHB, and CCNB1 expression.. Clin Cancer Res 14:4154-60.
Abstract

Molenaar JJ, Ebus ME, Koster J, van Sluis P, van Noesel CJ, Versteeg R, Caron HN, (2008). Cyclin D1 and CDK4 activity contribute to the undifferentiated phenotype in neuroblastoma.. Cancer Res 68:2599-609.
Abstract

Hatzis P, van der Flier LG, van Driel MA, Guryev V, Nielsen F, Denissov S, Nijman IJ, Koster J, Santo EE, Welboren W, Versteeg R, Cuppen E, van de Wetering M, Clevers H, Stunnenberg HG, (2008). Genome-wide pattern of TCF7L2/TCF4 chromatin occupancy in colorectal cancer cells.. Mol Cell Biol 28:2732-44.
Abstract

Revet I, Huizenga G, Chan A, Koster J, Volckmann R, van Sluis P, Ora I, Versteeg R, Geerts D, (2008). The MSX1 homeobox transcription factor is a downstream target of PHOX2B and activates the Delta-Notch pathway in neuroblastoma.. Exp Cell Res 314:707-19.
Abstract

Koppen A, Ait-Aissa R, Koster J, Ora I, Bras J, van Sluis PG, Caron H, Versteeg R, Valentijn LJ, (2008). Dickkopf-3 expression is a marker for neuroblastic tumor maturation and is down-regulated by MYCN.. Int J Cancer 122:1455-64.
Abstract

Geerts D, Wallick CJ, Koomoa DL, Koster J, Versteeg R, Go RC, Bachmann AS, (2007). Expression of prenylated Rab acceptor 1 domain family, member 2 (PRAF2) in neuroblastoma: correlation with clinical features, cellular localization, and cerulenin-mediated apoptosis regulation.. Clin Cancer Res 13:6312-9.
Abstract

Koppen A, Ait-Aissa R, Koster J, van Sluis PG, Ora I, Caron HN, Volckmann R, Versteeg R, Valentijn LJ, (2007). Direct regulation of the minichromosome maintenance complex by MYCN in neuroblastoma.. Eur J Cancer 43:2413-22.
Abstract

Michels E, Vandesompele J, De Preter K, Hoebeeck J, Vermeulen J, Schramm A, Molenaar JJ, Menten B, Marques B, Stallings RL, Combaret V, Devalck C, De Paepe A, Versteeg R, Eggert A, Laureys G, Van Roy N, Speleman F, (2007). ArrayCGH-based classification of neuroblastoma into genomic subgroups.. Genes Chromosomes Cancer 46:1098-108.
Abstract

Gierman HJ, Indemans MH, Koster J, Goetze S, Seppen J, Geerts D, van Driel R, Versteeg R, (2007). Domain-wide regulation of gene expression in the human genome.. Genome Res 17:1286-95.
Abstract

Koppen A, Ait-Aissa R, Hopman S, Koster J, Haneveld F, Versteeg R, Valentijn LJ, (2007). Dickkopf-1 is down-regulated by MYCN and inhibits neuroblastoma cell proliferation.. Cancer Lett 256:218-28.
Abstract

Zinner R, Teller K, Versteeg R, Cremer T, Cremer M, (2007). Biochemistry meets nuclear architecture: multicolor immuno-FISH for co-localization analysis of chromosome segments and differentially expressed gene loci with various histone methylations.. Adv Enzyme Regul 47:223-41.
Abstract

Henriksen JR, Lokke C, Hammero M, Geerts D, Versteeg R, Flaegstad T, Einvik C, (2007). Comparison of RNAi efficiency mediated by tetracycline-responsive H1 and U6 promoter variants in mammalian cell lines.. Nucleic Acids Res 35:e67.
Abstract

Goetze S, Mateos-Langerak J, Gierman HJ, de Leeuw W, Giromus O, Indemans MH, Koster J, Ondrej V, Versteeg R, van Driel R, (2007). The three-dimensional structure of human interphase chromosomes is related to the transcriptome map.. Mol Cell Biol 27:4475-87.
Abstract

de Haas T, Oussoren E, Grajkowska W, Perek-Polnik M, Popovic M, Zadravec-Zaletel L, Perera M, Corte G, Wirths O, van Sluis P, Pietsch T, Troost D, Baas F, Versteeg R, Kool M, (2006). OTX1 and OTX2 expression correlates with the clinicopathologic classification of medulloblastomas.. J Neuropathol Exp Neurol 65:176-86.
Abstract

Valentijn LJ, Koster J, Versteeg R, (2006). Read-through transcript from NM23-H1 into the neighboring NM23-H2 gene encodes a novel protein, NM23-LV.. Genomics 87:483-9.
Abstract

van Limpt V, Chan A, Schramm A, Eggert A, Versteeg R, (2005). Phox2B mutations and the Delta-Notch pathway in neuroblastoma.. Cancer Lett 228:59-63.
Abstract

Schramm A, Schulte JH, Astrahantseff K, Apostolov O, Limpt V, Sieverts H, Kuhfittig-Kulle S, Pfeiffer P, Versteeg R, Eggert A, (2005). Biological effects of TrkA and TrkB receptor signaling in neuroblastoma.. Cancer Lett 228:143-53.
Abstract

Geerts D, Revet I, Jorritsma G, Schilderink N, Versteeg R, (2005). MEIS homeobox genes in neuroblastoma.. Cancer Lett 228:43-50.
Abstract

Valentijn LJ, Koppen A, van Asperen R, Root HA, Haneveld F, Versteeg R, (2005). Inhibition of a new differentiation pathway in neuroblastoma by copy number defects of N-myc, Cdc42, and nm23 genes.. Cancer Res 65:3136-45.
Abstract

van Limpt V, Schramm A, van Lakeman A, Sluis P, Chan A, van Noesel M, Baas F, Caron H, Eggert A, Versteeg R, (2004). The Phox2B homeobox gene is mutated in sporadic neuroblastomas.. Oncogene 23:9280-8.
Abstract

van Noesel MM, Versteeg R, (2004). Pediatric neuroblastomas: genetic and epigenetic 'danse macabre'.. Gene 325:1-15.
Abstract

van Noesel MM, van Bezouw S, Voute PA, Herman JG, Pieters R, Versteeg R, (2003). Clustering of hypermethylated genes in neuroblastoma.. Genes Chromosomes Cancer 38:226-33.
Abstract

Versteeg R, van Schaik BD, van Batenburg MF, Roos M, Monajemi R, Caron H, Bussemaker HJ, van Kampen AH, (2003). The human transcriptome map reveals extremes in gene density, intron length, GC content, and repeat pattern for domains of highly and weakly expressed genes.. Genome Res 13:1998-2004.
Abstract

van Noesel MM, Pieters R, Voute PA, Versteeg R, (2003). The N-myc paradox: N-myc overexpression in neuroblastomas is associated with sensitivity as well as resistance to apoptosis.. Cancer Lett 197:165-72.
Abstract

Geerts D, Schilderink N, Jorritsma G, Versteeg R, (2003). The role of the MEIS homeobox genes in neuroblastoma.. Cancer Lett 197:87-92.
Abstract

Van Limpt VA, Chan AJ, Van Sluis PG, Caron HN, Van Noesel CJ, Versteeg R, (2003). High delta-like 1 expression in a subset of neuroblastoma cell lines corresponds to a differentiated chromaffin cell type.. Int J Cancer 105:61-9.
Abstract

Molenaar JJ, van Sluis P, Boon K, Versteeg R, Caron HN, (2003). Rearrangements and increased expression of cyclin D1 (CCND1) in neuroblastoma.. Genes Chromosomes Cancer 36:242-9.
Abstract

Van Roy N, Vandesompele J, Berx G, Staes K, Van Gele M, De Smet E, De Paepe A, Laureys G, van der Drift P, Versteeg R, Van Roy F, Speleman F, (2002). Localization of the 17q breakpoint of a constitutional 1;17 translocation in a patient with neuroblastoma within a 25-kb segment located between the ACCN1 and TLK2 genes and near the distal breakpoints of two microdeletions in neurofibromatosis type 1 patients.. Genes Chromosomes Cancer 35:113-20.
Abstract

Godfried MB, Veenstra M, Valent A, Sluis P, Voute PA, Versteeg R, Caron HN, (2002). Lack of interstitial chromosome 1p deletions in clinically-detected neuroblastoma.. Eur J Cancer 38:1513-9.
Abstract

Godfried MB, Veenstra M, v Sluis P, Boon K, v Asperen R, Hermus MC, v Schaik BD, Voute TP, Schwab M, Versteeg R, Caron HN, (2002). The N-myc and c-myc downstream pathways include the chromosome 17q genes nm23-H1 and nm23-H2.. Oncogene 21:2097-101.
Abstract

van Noesel MM, van Bezouw S, Salomons GS, Voute PA, Pieters R, Baylin SB, Herman JG, Versteeg R, (2002). Tumor-specific down-regulation of the tumor necrosis factor-related apoptosis-inducing ligand decoy receptors DcR1 and DcR2 is associated with dense promoter hypermethylation.. Cancer Res 62:2157-61.
Abstract

Spieker N, Beitsma M, Van Sluis P, Chan A, Caron H, Versteeg R, (2001). Three chromosomal rearrangements in neuroblastoma cluster within a 300-kb region on 1p36.1.. Genes Chromosomes Cancer 31:172-81.
Abstract

Boon K, Caron HN, van Asperen R, Valentijn L, Hermus MC, van Sluis P, Roobeek I, Weis I, Voute PA, Schwab M, Versteeg R, (2001). N-myc enhances the expression of a large set of genes functioning in ribosome biogenesis and protein synthesis.. EMBO J 20:1383-93.
Abstract

Caron H, van Schaik B, van der Mee M, Baas F, Riggins G, van Sluis P, Hermus MC, van Asperen R, Boon K, Voute PA, Heisterkamp S, van Kampen A, Versteeg R, (2001). The human transcriptome map: clustering of highly expressed genes in chromosomal domains.. Science 291:1289-92.
Abstract

Spieker N, van Sluis P, Beitsma M, Boon K, van Schaik BD, van Kampen AH, Caron H, Versteeg R, (2001). The MEIS1 oncogene is highly expressed in neuroblastoma and amplified in cell line IMR32.. Genomics 71:214-21.
Abstract

Caron H, Spieker N, Godfried M, Veenstra M, van Sluis P, de Kraker J, Voute P, Versteeg R, (2001). Chromosome bands 1p35-36 contain two distinct neuroblastoma tumor suppressor loci, one of which is imprinted.. Genes Chromosomes Cancer 30:168-74.
Abstract

van Kampen AH, van Schaik BD, Pauws E, Michiels EM, Ruijter JM, Caron HN, Versteeg R, Heisterkamp SH, Leunissen JA, Baas F, van der Mee M, (2000). USAGE: a web-based approach towards the analysis of SAGE data. Serial Analysis of Gene Expression.. Bioinformatics 16:899-905.
Abstract

van Limpt V, Chan A, Caron H, Sluis PV, Boon K, Hermus MC, Versteeg R, (2000). SAGE analysis of neuroblastoma reveals a high expression of the human homologue of the Drosophila Delta gene.. Med Pediatr Oncol 35:554-8.
Abstract

Spieker N, Beitsma M, van Sluis P, Roobeek I, den Dunnen JT, Speleman F, Caron H, Versteeg R, (2000). An integrated 5-Mb physical, genetic, and radiation hybrid map of a 1p36.1 region implicated in neuroblastoma pathogenesis.. Genes Chromosomes Cancer 27:143-52.
Abstract

van der Drift P, Chan A, Zehetner G, Westerveld A, Versteeg R, (1999). Multiple MSP pseudogenes in a local repeat cluster on 1p36.2: An expanding genomic graveyard?. Genomics 62:74-81.
Abstract

Wuyts W, Spieker N, Van Roy N, De Boulle K, De Paepe A, Willems PJ, Van Hul W, Versteeg R, Speleman F, (1999). Refined physical mapping and genomic structure of the EXTL1 gene.. Cytogenet Cell Genet 86:267-70.
Abstract

Van Gele M, Van Roy N, Ronan SG, Messiaen L, Vandesompele J, Geerts ML, Naeyaert JM, Blennow E, Bar-Am I, Das Gupta TK, van der Drift P, Versteeg R, Leonard JH, Speleman F, (1998). Molecular analysis of 1p36 breakpoints in two Merkel cell carcinomas.. Genes Chromosomes Cancer 23:67-71.
Abstract

Van Gele M, Van Roy N, Jauch A, Laureys G, Benoit Y, Schelfhout V, De Potter CR, Brock P, Uyttebroeck A, Sciot R, Schuuring E, Versteeg R, Speleman F, (1997). Sensitive and reliable detection of genomic imbalances in human neuroblastomas using comparative genomic hybridisation analysis.. Eur J Cancer 33:1979-82.
Abstract

Van Roy N, Laureys G, Van Gele M, Opdenakker G, Miura R, van der Drift P, Chan A, Versteeg R, Speleman F, (1997). Analysis of 1;17 translocation breakpoints in neuroblastoma: implications for mapping of neuroblastoma genes.. Eur J Cancer 33:1974-8.
Abstract

Van Roy N, Jauch A, Van Gele M, Laureys G, Versteeg R, De Paepe A, Cremer T, Speleman F, (1997). Comparative genomic hybridization analysis of human neuroblastomas: detection of distal 1p deletions and further molecular genetic characterization of neuroblastoma cell lines.. Cancer Genet Cytogenet 97:135-42.
Abstract

Versteeg R, (1997). Aberrant methylation in cancer.. Am J Hum Genet 60:751-4.
Abstract

Cheng NC, Beitsma M, Chan A, Op den Camp I, Westerveld A, Pronk J, Versteeg R, (1996). Lack of class I HLA expression in neuroblastoma is associated with high N-myc expression and hypomethylation due to loss of the MEMO-1 locus.. Oncogene 13:1737-44.
Abstract

Caron H, van Sluis P, Buschman R, Pereira do Tanque R, Maes P, Beks L, de Kraker J, Voute PA, Vergnaud G, Westerveld A, Slater R, Versteeg R, (1996). Allelic loss of the short arm of chromosome 4 in neuroblastoma suggests a novel tumour suppressor gene locus.. Hum Genet 97:834-7.
Abstract

Cheng NC, Chan AJ, Beitsma MM, Speleman F, Westerveld A, Versteeg R, (1996). A human modifier of methylation for class I HLA genes (MEMO-1) maps to chromosomal bands 1p35-36.1.. Hum Mol Genet 5:309-17.
Abstract

Hofstra RM, Cheng NC, Hansen C, Stulp RP, Stelwagen T, Clausen N, Tommerup N, Caron H, Westerveld A, Versteeg R, Buys CH, (1996). No mutations found by RET mutation scanning in sporadic and hereditary neuroblastoma.. Hum Genet 97:362-4.
Abstract

Caron H, van Sluis P, de Kraker J, Bokkerink J, Egeler M, Laureys G, Slater R, Westerveld A, Voute PA, Versteeg R, (1996). Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma.. N Engl J Med 334:225-30.
Abstract

van der Drift P, Chan A, Laureys G, van Roy N, Sickmann G, den Dunnen J, Westerveld A, Speleman F, Versteeg R, (1995). Balanced translocation in a neuroblastoma patient disrupts a cluster of small nuclear RNA U1 and tRNA genes in chromosomal band 1p36.. Genes Chromosomes Cancer 14:35-42.
Abstract

Van Roy N, Forus A, Myklebost O, Cheng NC, Versteeg R, Speleman F, (1995). Identification of two distinct chromosome 12-derived amplification units in neuroblastoma cell line NGP.. Cancer Genet Cytogenet 82:151-4.
Abstract

Laureys G, Speleman F, Versteeg R, van der Drift P, Chan A, Leroy J, Francke U, Opdenakker G, Van Roy N, (1995). Constitutional translocation t(1;17)(p36.31-p36.13;q11.2-q12.1) in a neuroblastoma patient. Establishment of somatic cell hybrids and identification of PND/A12M2 on chromosome 1 and NF1/SCYA7 on chromosome 17 as breakpoint flanking single copy markers.. Oncogene 10:1087-93.
Abstract

Cheng NC, Van Roy N, Chan A, Beitsma M, Westerveld A, Speleman F, Versteeg R, (1995). Deletion mapping in neuroblastoma cell lines suggests two distinct tumor suppressor genes in the 1p35-36 region, only one of which is associated with N-myc amplification.. Oncogene 10:291-7.
Abstract

Versteeg R, Caron H, Cheng NC, van der Drift P, Slater R, Westerveld A, Voute PA, Delattre O, Laureys G, Van Roy N, et al., (1995). 1p36: every subband a suppressor?. Eur J Cancer 31A:538-41.
Abstract

Van Roy N, Cheng NC, Laureys G, Opdenakker G, Versteeg R, Speleman F, (1995). Molecular cytogenetic analysis of 1;17 translocations in neuroblastoma.. Eur J Cancer 31A:530-5.
Abstract

Laureys G, Versteeg R, Speleman F, van der Drift P, Francke U, Opdenakker G, Van Roy N, (1995). Characterisation of the chromosome breakpoints in a patient with a constitutional translocation t(1;17)(p36.31-p36.13;q11.2-q12) and neuroblastoma.. Eur J Cancer 31A:523-6.
Abstract

van der Drift P, Chan A, van Roy N, Laureys G, Westerveld A, Speleman F, Versteeg R, (1994). A multimegabase cluster of snRNA and tRNA genes on chromosome 1p36 harbours an adenovirus/SV40 hybrid virus integration site.. Hum Mol Genet 3:2131-6.
Abstract

Caron H, van Sluis P, van Roy N, de Kraker J, Speleman F, Voute PA, Westerveld A, Slater R, Versteeg R, (1994). Recurrent 1;17 translocations in human neuroblastoma reveal nonhomologous mitotic recombination during the S/G2 phase as a novel mechanism for loss of heterozygosity.. Am J Hum Genet 55:341-7.
Abstract

Van Roy N, Laureys G, Cheng NC, Willem P, Opdenakker G, Versteeg R, Speleman F, (1994). 1;17 translocations and other chromosome 17 rearrangements in human primary neuroblastoma tumors and cell lines.. Genes Chromosomes Cancer 10:103-14.
Abstract

Van Roy N, Laureys G, Versteeg R, Opdenakker G, Speleman F, (1993). High-resolution fluorescence mapping of 46 DNA markers to the short arm of human chromosome 1.. Genomics 18:71-8.
Abstract

Caron H, van Sluis P, van Hoeve M, de Kraker J, Bras J, Slater R, Mannens M, Voute PA, Westerveld A, Versteeg R, (1993). Allelic loss of chromosome 1p36 in neuroblastoma is of preferential maternal origin and correlates with N-myc amplification.. Nat Genet 4:187-90.
Abstract

Boschman GA, Rens W, Manders EM, Slater RM, Versteeg R, Aten JA, (1992). Detection of recurrent chromosome abnormalities in Ewing's sarcoma and peripheral neuroectodermal tumor cells using bivariate flow karyotyping.. Genes Chromosomes Cancer 5:375-84.
Abstract

Versteeg R, (1992). NK cells and T cells: mirror images?. Immunol Today 13:244-7.
Abstract

Schrier PI, Versteeg R, Peltenburg LT, Plomp AC, van t Veer LJ, Kruse-Wolters KM, (1991). Sensitivity of melanoma cell lines to natural killer cells: a role for oncogene-modulated HLA class I expression?. Semin Cancer Biol 2:73-83.
Abstract

Versteeg R, van der Minne C, Plomp A, Sijts A, van Leeuwen A, Schrier P, (1990). N-myc expression switched off and class I human leukocyte antigen expression switched on after somatic cell fusion of neuroblastoma cells.. Mol Cell Biol 10:5416-23.
Abstract

Versteeg R, Peltenburg LT, Plomp AC, Schrier PI, (1989). High expression of the c-myc oncogene renders melanoma cells prone to lysis by natural killer cells.. J Immunol 143:4331-7.
Abstract

Versteeg R, Kruse-Wolters KM, Plomp AC, van Leeuwen A, Stam NJ, Ploegh HL, Ruiter DJ, Schrier PI, (1989). Suppression of class I human histocompatibility leukocyte antigen by c-myc is locus specific.. J Exp Med 170:621-35.
Abstract

van t Veer LJ, Burgering BM, Versteeg R, Boot AJ, Ruiter DJ, Osanto S, Schrier PI, Bos JL, (1989). N-ras mutations in human cutaneous melanoma from sun-exposed body sites.. Mol Cell Biol 9:3114-6.
Abstract

Versteeg R, Noordermeer IA, Kruse-Wolters M, Ruiter DJ, Schrier PI, (1988). c-myc down-regulates class I HLA expression in human melanomas.. EMBO J 7:1023-9.
Abstract

Konings A, Hupkes P, Versteeg R, Grosveld G, Reuser A, Galjaard H, (1984). Cloning a cDNA for the lysosomal alpha-glucosidase.. Biochem Biophys Res Commun 119:252-8.
Abstract

Van der Avoort HG, Teertstra R, Versteeg R, Weisbeek PJ, (1983). Genes and regulatory sequences of bacteriophage phi X174.. Biochim Biophys Acta 741:94-102.
Abstract